James Folmar Reddoch Ph.D.
Net Worth

Last updated:

What is James Folmar Reddoch Ph.D. net worth?

The estimated net worth of Dr. James Folmar Reddoch Ph.D. is at least $74,634,030 as of 28 Sep 2022. He owns shares worth $29,335,392 as insider, has earned $31,698,638 from insider trading and has received compensation worth at least $13,600,000 in Royalty Pharma plc.

What is the salary of James Folmar Reddoch Ph.D.?

Dr. James Folmar Reddoch Ph.D. salary is $3,400,000 per year as Executive Vice President, Chief Scientific Officer and Co-Head of Research & Investments in Royalty Pharma plc.

How old is James Folmar Reddoch Ph.D.?

Dr. James Folmar Reddoch Ph.D. is 55 years old, born in 1970.

What stocks does James Folmar Reddoch Ph.D. currently own?

As insider, Dr. James Folmar Reddoch Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Royalty Pharma plc (RPRX) Executive Vice President, Chief Scientific Officer and Co-Head of Research & Investments 820,800 $35.74 $29,335,392

What does Royalty Pharma plc do?

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

RPRX logo
RPRX
Royalty Pharma plc
$35.74

James Folmar Reddoch Ph.D. insider trading

Royalty Pharma plc

Dr. James Folmar Reddoch Ph.D. has made 19 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of RPRX stock worth $4,122,700 on 28 Sep 2022.

The largest trade he's ever made was exercising 100,000 units of RPRX stock on 2 Mar 2021. As of 28 Sep 2022 he still owns at least 820,800 units of RPRX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Ordinary Shares 100,000 $41.23 $4,122,700
Sale
Class A Ordinary Shares 100,000 $41.56 $4,155,900
Sale
Class A Ordinary Shares 75,000 $41.08 $3,081,000
Sale
Class A Ordinary Shares 8,949 N/A N/A
Sale
Class A Ordinary Shares 2 N/A N/A
Sale
Class A Ordinary Shares 17,832 N/A N/A
Sale
Class A Ordinary Shares 100 N/A N/A
Sale
Class A Ordinary Shares 40,655 N/A N/A
Sale
Class A Ordinary Shares 2,192 N/A N/A
Sale
Class A Ordinary Shares 30,270 N/A N/A
Sale
Class A Ordinary Shares 50,000 $46.43 $2,321,550
Sale
Class A Ordinary Shares 50,000 $46.79 $2,339,500
Sale
Class A Ordinary Shares 50,000 $46.79 $2,339,500
Sale
Class A Ordinary Shares 100,000 $44.6 $4,459,700
Sale
Class A Ordinary Shares 50,000 $42.13 $2,106,550
Sale
Class A Ordinary Shares 55,714 $42.1 $2,345,615
Sale
Class A Ordinary Shares 359 N/A N/A
Sale
Class A Ordinary Shares 43,927 $46.32 $2,034,523
Sale
Class A Ordinary Shares 100,000 $23.92 $2,392,100

Royalty Pharma key executives

Royalty Pharma plc executives and other stock owners filed with the SEC: